Dissecting tumor transcriptional heterogeneity from single-cell RNA-seq data by generalized binary covariance...

Area of Science:

• Oncology
• Bioinformatics
• Computational Biology

Background:

• Single-cell RNA sequencing (scRNA-seq) offers insights into tumor progression and therapeutic targets.
• Intertumor heterogeneity in cancer can mask shared, subtle transcriptional patterns.
• Existing methods struggle to disentangle complex transcriptional variations across diverse tumors.

Purpose of the Study:

• To introduce a novel statistical method, generalized binary covariance decomposition (GBCD), for analyzing transcriptional heterogeneity in tumors.
• To address the challenge of intertumor heterogeneity obscuring shared biological signals.
• To improve the interpretability of scRNA-seq data in cancer research.

Main Methods:

• Development and application of generalized binary covariance decomposition (GBCD).
• Decomposition of transcriptional heterogeneity into patient-specific, dataset-specific, and shared components.
• Comparative analysis against existing methods in the presence of strong intertumor heterogeneity.

Main Results:

• GBCD effectively decomposes transcriptional heterogeneity into interpretable components.
• The method provides more interpretable results than existing approaches when intertumor heterogeneity is high.
• Application to pancreatic ductal adenocarcinoma data refined subtype characterization.
• Identification of a novel gene expression program linked to poor survival, independent of stage and subtype.

Conclusions:

• GBCD is a powerful tool for dissecting complex tumor transcriptional landscapes.
• The identified gene expression program highlights the role of stress responses, specifically the integrated stress response, in pancreatic ductal adenocarcinoma prognosis.
• This finding suggests potential new avenues for therapeutic intervention in pancreatic cancer.